{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:44Z","timestamp":1783555244367,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To assess the safety and efficacy of endocyclophotocoagulation with phacoemulsification (phaco-ECP) in surgically naive, primary open-angle glaucoma (POAG).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective case series of patients undergoing phaco-ECP between 2007 and 2017 at a single centre in London, UK. The primary outcome was intraocular pressure (IOP). Secondary outcomes were visual acuity, visual field global indices, topical medications and surgical complications. Failure criteria were: (1) IOP &gt; 21\u2009mmHg or &lt;20% reduction at two consecutive visits, (2) IOP &lt;5\u2009mmHg and (3) further IOP-lowering surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty-three eyes from 83 patients were eligible. Pre-operatively, mean IOP (\u00b1SD) was 18.4\u2009\u00b1\u20095.2\u2009mmHg. The mean number of topical agents (\u00b1SD) was 2.7\u2009\u00b1\u20090.9. Mean IOP (\u00b1SD) significantly reduced to 14.3\u2009\u00b1\u20094.7 at 1 year, 14.1\u2009\u00b1\u20094.0 at 2 years and 13.6\u2009\u00b1\u20093.7 at 3 years (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Topical medications were significantly reduced to 1.3\u2009\u00b1\u20091.2 at 1 year, 1.7\u2009\u00b1\u20091.2 at 2 years and 1.8\u2009\u00b1\u20091.3 at 3 years (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Annual IOP \u2018survival\u2019 was 70%, 54% and 45% at year 1, 2 and 3, respectively. Complications included uveitis (6%), macular oedema (2%), IOP spikes (1%) and corneal decompensation (1%) with no episodes of hypotony or retinal detachment. One patient underwent filtration surgery within 3 years (1%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Phaco-ECP facilitates significant IOP lowering and reduction of medication burden in surgically naive POAG requiring cataract extraction. The procedure is relatively safe and without the use of implants and their associated risks.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-021-01734-4","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T17:05:35Z","timestamp":1631725535000},"page":"1890-1895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Endocyclophotocoagulation combined with phacoemulsification in surgically naive primary open-angle glaucoma: three-year results"],"prefix":"10.1038","volume":"36","author":[{"given":"Timothy E.","family":"Yap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-7533","authenticated-orcid":false,"given":"Piero","family":"Zollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Husein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M. M.","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-6008","authenticated-orcid":false,"given":"Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"1734_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901\u201311.","journal-title":"JAMA."},{"key":"1734_CR2","doi-asserted-by":"crossref","unstructured":"Gaasterland DE, Ederer F, Beck A, Costarides A, Leef D, Closek J, et al. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429\u201340.","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"1734_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0002-9394(01)00964-3","volume":"131","author":"S Drance","year":"2001","unstructured":"Drance S, Anderson DR, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699\u2013708.","journal-title":"Am J Ophthalmol"},{"key":"1734_CR4","doi-asserted-by":"crossref","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Philip Miller J, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313.","DOI":"10.1001\/archopht.120.6.701"},{"key":"1734_CR5","doi-asserted-by":"crossref","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268\u201379.","DOI":"10.1001\/archopht.120.10.1268"},{"key":"1734_CR6","doi-asserted-by":"crossref","unstructured":"Berens C. Glaucoma surgery: an evaluation of cycloelectrolysis and cyclodiothermy. AMA Arch Ophthalmol. 1955;54:548\u201363.","DOI":"10.1001\/archopht.1955.00930020554008"},{"key":"1734_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ceo.12360","volume":"43","author":"MCD Aquino","year":"2015","unstructured":"Aquino MCD, Barton K, Tan AMWT, Sng C, Li X, Loon SC, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43:40\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"1734_CR8","doi-asserted-by":"crossref","unstructured":"Uram M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology. 1992;99:1823\u20138.","DOI":"10.1016\/S0161-6420(92)31718-X"},{"key":"1734_CR9","doi-asserted-by":"crossref","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119:694\u2013702.","DOI":"10.1016\/j.ophtha.2011.09.043"},{"key":"1734_CR10","doi-asserted-by":"crossref","unstructured":"Mathew DJ, Buys YM. Minimally invasive glaucoma surgery: a critical appraisal of the literature. Annu Rev Vis Sci. 2020;6:47\u201389.","DOI":"10.1146\/annurev-vision-121219-081737"},{"key":"1734_CR11","doi-asserted-by":"crossref","unstructured":"Francis BA, Berke SJ, Dustin L, Noecker R. Endoscopic cyclophotocoagulation combined with phacoemulsification versus phacoemulsification alone in medically controlled glaucoma. J Cataract Refract Surg. 2014;40:1313\u201321.","DOI":"10.1016\/j.jcrs.2014.06.021"},{"key":"1734_CR12","doi-asserted-by":"crossref","unstructured":"Siegel MJ, Boling WS, Faridi OS, Gupta CK, Kim C, Boling RC, et al. Combined endoscopic cyclophotocoagulation and phacoemulsification versus phacoemulsification alone in the treatment of mild to moderate glaucoma. Clin Experiment Ophthalmol. 2015;43:531\u20139.","DOI":"10.1111\/ceo.12510"},{"key":"1734_CR13","doi-asserted-by":"crossref","unstructured":"P\u00e9rez Bartolom\u00e9 F, Rodrigues IA, Goyal S, Bloch E, Lim WS, Alaghband P, et al. Phacoemulsification plus endoscopic cyclophotocoagulation versus phacoemulsification alone in primary open-angle glaucoma. Eur J Ophthalmol. 2018;28:168\u201374.","DOI":"10.5301\/ejo.5001034"},{"key":"1734_CR14","doi-asserted-by":"publisher","first-page":"e000578","DOI":"10.1136\/bmjopen-2011-000578","volume":"2","author":"D Lindfield","year":"2012","unstructured":"Lindfield D, Ritchie RW, Griffiths MFP. \u2018Phaco\u2013ECP\u2019: combined endoscopic cyclophotocoagulation and cataract surgery to augment medical control of glaucoma. BMJ Open. 2012;2:e000578.","journal-title":"BMJ Open"},{"key":"1734_CR15","doi-asserted-by":"crossref","unstructured":"Lima FEL, de Carvalho DM, de \u00c1vila MP. Phacoemulsification and endoscopic cyclophotocoagulation as primary surgical procedure in coexisting cataract and glaucoma. Arq Bras Oftalmol. 2010;73:419\u201322.","DOI":"10.1590\/S0004-27492010000500006"},{"key":"1734_CR16","doi-asserted-by":"crossref","unstructured":"Smith M, Byles D, Lim LA. Phacoemulsification and endocyclophotocoagulation in uncontrolled glaucoma: three-year results. J Cataract Refract Surg. 2018;44:1097\u2013102.","DOI":"10.1016\/j.jcrs.2018.06.025"},{"key":"1734_CR17","doi-asserted-by":"crossref","unstructured":"Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388\u201391.","DOI":"10.3928\/1081-597X-19970701-16"},{"key":"1734_CR18","doi-asserted-by":"crossref","unstructured":"Morales J, Al Qahtani M, Khandekar R, Al Shahwan S, Al Odhayb S, Al Mobarak F, et al. Intraocular pressure following phacoemulsification and endoscopic cyclophotocoagulation for advanced glaucoma: 1-year outcomes. J Glaucoma. 2015;24:e157\u201362.","DOI":"10.1097\/IJG.0000000000000228"},{"key":"1734_CR19","unstructured":"Roberts SJ, Mulvahill M, SooHoo JR, Pantcheva MB, Kahook MY, Seibold LK. Efficacy of combined cataract extraction and endoscopic cyclophotocoagulation for the reduction of intraocular pressure and medication burden. Int J Ophthalmol. 2016;9:693\u20138."},{"key":"1734_CR20","doi-asserted-by":"crossref","unstructured":"Waldman CW, Desai M, Rahman EZ, Eliassi-Rad B. Combined endocyclophotocoagulation and phacoemulsification in patients with glaucoma of African descent. Med Hypothesis Discov Innov Ophthalmol. 2019;8:257\u201365.","DOI":"10.21203\/rs.2.242\/v1"},{"key":"1734_CR21","doi-asserted-by":"crossref","unstructured":"Clement CI, Kampougeris G, Ahmed F, Cordeiro MF, Bloom PA. Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin Experiment Ophthalmol. 2013;41:546\u201351.","DOI":"10.1111\/ceo.12051"},{"key":"1734_CR22","doi-asserted-by":"crossref","unstructured":"Izquierdo Villavicencio JC, Gonzalez Mendez AL, Ramirez Jimenez I, Quezada Baltodano FP, Araujo Segura RC, Franco LS, et al. Clinical results of endocyclophotocoagulation in patients with cataract and open-angle glaucoma at Oftalmosalud Eye Institute, Lima-Peru. J Clin Exp Ophthalmol. 2018;9:6.","DOI":"10.4172\/2155-9570.1000762"},{"key":"1734_CR23","doi-asserted-by":"crossref","unstructured":"Lin SC, Chen MJ, Lin MS, Howes E, Stamper RL. Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation. Br J Ophthalmol. 2006;90:496\u2013500.","DOI":"10.1136\/bjo.2005.072777"},{"key":"1734_CR24","doi-asserted-by":"crossref","unstructured":"Malvankar-Mehta MS, Iordanous Y, Chen YN, Wang WW, Patel SS, Costella J, et al. IStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS One. 2015;10:e0131770.","DOI":"10.1371\/journal.pone.0131770"},{"key":"1734_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1136\/bjophthalmol-2019-315434","volume":"104","author":"AD Pantalon","year":"2020","unstructured":"Pantalon AD, Barata ADDO, Georgopoulos M, Ratnarajan G. Outcomes of phacoemulsification combined with two iStent inject trabecular microbypass stents with or without endocyclophotocoagulation. Br J Ophthalmol. 2020;104:1378\u201383.","journal-title":"Br J Ophthalmol"},{"key":"1734_CR26","doi-asserted-by":"crossref","unstructured":"Tan SZ, Au L. Manchester iStent study: 3-year results and cost analysis. Eye (Lond). 2016;30:1365\u201370.","DOI":"10.1038\/eye.2016.139"},{"key":"1734_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/IJG.0000000000001245","volume":"28","author":"H Ho","year":"2019","unstructured":"Ho H, Ho J, Rodrigues I, Syrimi M, Goyal S, Lim KS. The cost and economics of endoscopic cyclophotocoagulation in the United Kingdom: a tertiary center experience. J Glaucoma. 2019;28:563\u20137.","journal-title":"J Glaucoma"},{"key":"1734_CR28","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/IJG.0b013e31829d9bc7","volume":"23","author":"Y Iordanous","year":"2014","unstructured":"Iordanous Y, Kent JS, Hutnik CML, Malvankar-Mehta MS. Projected cost comparison of Trabectome, iStent, and endoscopic cyclophotocoagulation versus glaucoma medication in the Ontario Health Insurance Plan. J Glaucoma. 2014;23:e112\u20138.","journal-title":"J Glaucoma"},{"key":"1734_CR29","doi-asserted-by":"crossref","unstructured":"Gayton JL, Van Der Karr M, Sanders V. Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation. J Cataract Refract Surg. 1999;25:1214\u20139.","DOI":"10.1016\/S0886-3350(99)00141-8"},{"key":"1734_CR30","doi-asserted-by":"crossref","unstructured":"Bendel RE, Patterson MT. Long-term effectiveness of trabectome (Ab-interno trabeculectomy) surgery. J Curr Glaucoma Pract. 2018;12:119\u201324.","DOI":"10.5005\/jp-journals-10078-1235"},{"key":"1734_CR31","doi-asserted-by":"crossref","unstructured":"Lewis RA, Von Wolff K, Tetz M, Koerber N, Kearney JR, Shingleton BJ, et al. Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg. 2011;37:682\u201390.","DOI":"10.1016\/j.jcrs.2010.10.055"},{"key":"1734_CR32","doi-asserted-by":"crossref","unstructured":"Moghimi S, Hamzeh N, Mohammadi M, Khatibi N, Bowd C, Weinreb RN. Combined glaucoma and cataract surgery: comparison of viscocanalostomy, endocyclophotocoagulation, and ab interno trabeculectomy. J Cataract Refract Surg. 2018;44:557\u201365.","DOI":"10.1016\/j.jcrs.2018.03.024"},{"key":"1734_CR33","unstructured":"Aliendres JL, Villavicencio JCI, Menzel CG, S\u00e1nchez MR, Carmen Maldonado JC. Comparison of combined glaucoma and cataract surgery: canaloplasty Ab interno and micropulse v\/s ab interno trabeculectomy and endocyclophotocoagulation. Invest Ophthalmol Vis Sci 2020;61:3156."},{"key":"1734_CR34","doi-asserted-by":"crossref","unstructured":"Klug E, Chachanidze M, Nirappel A, Chang EK, Hall N, Chang TC, et al. Outcomes of phacoemulsification and endoscopic cyclophotocoagulation performed with dual blade ab interno trabeculectomy or trabecular micro-bypass stent insertion. Eye (Lond). 2021. Online ahead of print.","DOI":"10.1038\/s41433-021-01475-4"},{"key":"1734_CR35","doi-asserted-by":"crossref","unstructured":"Ishida K. Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol. 2013;24:102\u201310.","DOI":"10.1097\/ICU.0b013e32835d9335"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01734-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01734-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T16:14:17Z","timestamp":1663863257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01734-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01734-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PAB has received honoraria and speakers\u2019 fees from EndoOptiks UK and BVI Medical. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}